These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 21684519)
1. ER-α36, a novel variant of estrogen receptor α, is involved in EGFR-related carcinogenesis in endometrial cancer. Tu BB; Lin SL; Yan LY; Wang ZY; Sun QY; Qiao J Am J Obstet Gynecol; 2011 Sep; 205(3):227.e1-6. PubMed ID: 21684519 [TBL] [Abstract][Full Text] [Related]
2. A novel variant of ER-alpha, ER-alpha36 mediates testosterone-stimulated ERK and Akt activation in endometrial cancer Hec1A cells. Lin SL; Yan LY; Liang XW; Wang ZB; Wang ZY; Qiao J; Schatten H; Sun QY Reprod Biol Endocrinol; 2009 Sep; 7():102. PubMed ID: 19775474 [TBL] [Abstract][Full Text] [Related]
3. ER-alpha36, a variant of ER-alpha, promotes tamoxifen agonist action in endometrial cancer cells via the MAPK/ERK and PI3K/Akt pathways. Lin SL; Yan LY; Zhang XT; Yuan J; Li M; Qiao J; Wang ZY; Sun QY PLoS One; 2010 Feb; 5(2):e9013. PubMed ID: 20126312 [TBL] [Abstract][Full Text] [Related]
4. ER-α36, a novel variant of ER-α, mediates estrogen-stimulated proliferation of endometrial carcinoma cells via the PKCδ/ERK pathway. Tong JS; Zhang QH; Wang ZB; Li S; Yang CR; Fu XQ; Hou Y; Wang ZY; Sheng J; Sun QY PLoS One; 2010 Nov; 5(11):e15408. PubMed ID: 21079811 [TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor signaling enhanced by long-term medroxyprogesterone acetate treatment in endometrial carcinoma. Zhao S; Chen X; Lu X; Yu Y; Feng Y Gynecol Oncol; 2007 Apr; 105(1):45-54. PubMed ID: 17240435 [TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor-α variant, ER-α36, is involved in tamoxifen resistance and estrogen hypersensitivity. Zhang X; Wang ZY Endocrinology; 2013 Jun; 154(6):1990-8. PubMed ID: 23546601 [TBL] [Abstract][Full Text] [Related]
7. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors. Creighton CJ; Hilger AM; Murthy S; Rae JM; Chinnaiyan AM; El-Ashry D Cancer Res; 2006 Apr; 66(7):3903-11. PubMed ID: 16585219 [TBL] [Abstract][Full Text] [Related]
8. Protein kinase C alpha expression is inversely related to ER status in endometrial carcinoma: possible role in AP-1-mediated proliferation of ER-negative endometrial cancer. Fournier DB; Chisamore M; Lurain JR; Rademaker AW; Jordan VC; Tonetti DA Gynecol Oncol; 2001 Jun; 81(3):366-72. PubMed ID: 11371124 [TBL] [Abstract][Full Text] [Related]
9. Estrogen-independent effects of ER-α36 in ER-negative breast cancer. Zhang J; Li G; Li Z; Yu X; Zheng Y; Jin K; Wang H; Gong Y; Sun X; Teng X; Cao J; Teng L Steroids; 2012 May; 77(6):666-73. PubMed ID: 22402113 [TBL] [Abstract][Full Text] [Related]
10. ER-α36 mediates cisplatin resistance in breast cancer cells through EGFR/HER-2/ERK signaling pathway. Zhu L; Zou J; Zhao Y; Jiang X; Wang Y; Wang X; Chen B J Exp Clin Cancer Res; 2018 Jun; 37(1):123. PubMed ID: 29940998 [TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor-positive human epithelial ovarian carcinoma cells respond to the antitumor drug suramin with increased proliferation: possible insight into ER and epidermal growth factor signaling interactions in ovarian cancer. Kalli KR; Bradley SV; Fuchshuber S; Conover CA Gynecol Oncol; 2004 Sep; 94(3):705-12. PubMed ID: 15350362 [TBL] [Abstract][Full Text] [Related]
12. E-cadherin, as a negative regulator of invasive behavior of human trophoblast cells, is down-regulated by cyclosporin A via epidermal growth factor/extracellular signal-regulated protein kinase signaling pathway. Zhao HB; Wang C; Li RX; Tang CL; Li MQ; Du MR; Hou XF; Li DJ Biol Reprod; 2010 Sep; 83(3):370-6. PubMed ID: 20427760 [TBL] [Abstract][Full Text] [Related]
13. Long-term treatment with tamoxifen facilitates translocation of estrogen receptor alpha out of the nucleus and enhances its interaction with EGFR in MCF-7 breast cancer cells. Fan P; Wang J; Santen RJ; Yue W Cancer Res; 2007 Feb; 67(3):1352-60. PubMed ID: 17283173 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of estrogen receptor-alpha in the endometrial carcinoma cell line Ishikawa: inhibition of growth and angiogenic factors. Ali SH; O'Donnell AL; Mohamed S; Mousa S; Dandona P Gynecol Oncol; 2004 Dec; 95(3):637-45. PubMed ID: 15581976 [TBL] [Abstract][Full Text] [Related]
15. Estrogen activation of the mitogen-activated protein kinase is mediated by ER-α36 in ER-positive breast cancer cells. Zhang X; Deng H; Wang ZY J Steroid Biochem Mol Biol; 2014 Sep; 143():434-43. PubMed ID: 24973581 [TBL] [Abstract][Full Text] [Related]
16. Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action. Migliaccio A; Di Domenico M; Castoria G; Nanayakkara M; Lombardi M; de Falco A; Bilancio A; Varricchio L; Ciociola A; Auricchio F Cancer Res; 2005 Nov; 65(22):10585-93. PubMed ID: 16288052 [TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor-induced cyclooxygenase-2 expression is mediated through phosphatidylinositol-3 kinase, not mitogen-activated protein/extracellular signal-regulated kinase kinase, in recurrent respiratory papillomas. Wu R; Abramson AL; Shikowitz MJ; Dannenberg AJ; Steinberg BM Clin Cancer Res; 2005 Sep; 11(17):6155-61. PubMed ID: 16144915 [TBL] [Abstract][Full Text] [Related]
18. Activation of proteinase-activated receptor 1 promotes human colon cancer cell proliferation through epidermal growth factor receptor transactivation. Darmoul D; Gratio V; Devaud H; Peiretti F; Laburthe M Mol Cancer Res; 2004 Sep; 2(9):514-22. PubMed ID: 15383630 [TBL] [Abstract][Full Text] [Related]
19. The expression and role of hybrid insulin/insulin-like growth factor receptor type 1 in endometrial carcinoma cells. Zhang G; Li X; Zhang L; Zhao L; Jiang J; Wang J; Wei L Cancer Genet Cytogenet; 2010 Jul; 200(2):140-8. PubMed ID: 20620597 [TBL] [Abstract][Full Text] [Related]
20. The ER-α36/EGFR signaling loop promotes growth of hepatocellular carcinoma cells. You H; Meng K; Wang ZY Steroids; 2018 Jun; 134():78-87. PubMed ID: 29481815 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]